{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T01:44:56Z","timestamp":1792374296925,"version":"4.4.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s11845-023-03380-z","type":"journal-article","created":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T01:02:05Z","timestamp":1685408525000},"page":"199-209","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Prophylactic administration of metformin reduces gestational diabetes mellitus incidence in the high-risk populations: a meta-analysis"],"prefix":"10.1007","volume":"193","author":[{"given":"Hui","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinling","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1371-567X","authenticated-orcid":false,"given":"Honglei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,30]]},"reference":[{"key":"3380_CR1","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1210\/endrev\/bnac003","volume":"43","author":"A Sweeting","year":"2022","unstructured":"Sweeting A, Wong J, Murphy HR et al (2022) A Clinical Update on Gestational Diabetes Mellitus. Endocr Rev 43:763\u2013793. https:\/\/doi.org\/10.1210\/endrev\/bnac003","journal-title":"Endocr Rev"},{"key":"3380_CR2","doi-asserted-by":"publisher","unstructured":"Juan J, Yang H (2020) Prevalence, Prevention, and Lifestyle Intervention of Gestational Diabetes Mellitus in China. Int J Environ Res Public Health 17. https:\/\/doi.org\/10.3390\/ijerph17249517","DOI":"10.3390\/ijerph17249517"},{"key":"3380_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11892-015-0699-x","volume":"16","author":"Y Zhu","year":"2016","unstructured":"Zhu Y, Zhang C (2016) Prevalence of Gestational Diabetes and Risk of Progression to Type 2 Diabetes: a Global Perspective. Curr Diab Rep 16:7. https:\/\/doi.org\/10.1007\/s11892-015-0699-x","journal-title":"Curr Diab Rep"},{"key":"3380_CR4","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nrendo.2012.96","volume":"8","author":"TA Buchanan","year":"2012","unstructured":"Buchanan TA, Xiang AH, Page KA (2012) Gestational diabetes mellitus: risks and management during and after pregnancy. Nat Rev Endocrinol 8:639\u2013649. https:\/\/doi.org\/10.1038\/nrendo.2012.96","journal-title":"Nat Rev Endocrinol"},{"key":"3380_CR5","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1186\/s12884-018-2131-4","volume":"18","author":"KW Lee","year":"2018","unstructured":"Lee KW, Ching SM, Ramachandran V et al (2018) Prevalence and risk factors of gestational diabetes mellitus in Asia: a systematic review and meta-analysis. BMC Pregnancy Childbirth 18:494. https:\/\/doi.org\/10.1186\/s12884-018-2131-4","journal-title":"BMC Pregnancy Childbirth"},{"key":"3380_CR6","doi-asserted-by":"publisher","unstructured":"Ye W, Luo C, Huang J et al (2022) Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis. BMJ 377:e067946. https:\/\/doi.org\/10.1136\/bmj-2021-067946","DOI":"10.1136\/bmj-2021-067946"},{"key":"3380_CR7","doi-asserted-by":"publisher","unstructured":"Saravanan P, Diabetes in Pregnancy Working G, Maternal Medicine Clinical Study G et al (2020) Gestational diabetes: opportunities for improving maternal and child health. Lancet Diabetes Endocrinol 8:793\u2013800. https:\/\/doi.org\/10.1016\/S2213-8587(20)30161-3","DOI":"10.1016\/S2213-8587(20)30161-3"},{"key":"3380_CR8","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1007\/s00125-019-4961-7","volume":"62","author":"K Benhalima","year":"2019","unstructured":"Benhalima K, Van Crombrugge P, Moyson C et al (2019) Characteristics and pregnancy outcomes across gestational diabetes mellitus subtypes based on insulin resistance. Diabetologia 62:2118\u20132128. https:\/\/doi.org\/10.1007\/s00125-019-4961-7","journal-title":"Diabetologia"},{"key":"3380_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4093\/dmj.2021.0335","volume":"46","author":"JH Moon","year":"2022","unstructured":"Moon JH, Jang HC (2022) Gestational Diabetes Mellitus: Diagnostic Approaches and Maternal-Offspring Complications. Diabetes Metab J 46:3\u201314. https:\/\/doi.org\/10.4093\/dmj.2021.0335","journal-title":"Diabetes Metab J"},{"key":"3380_CR10","doi-asserted-by":"publisher","first-page":"3833","DOI":"10.2174\/1381612827666210125155428","volume":"27","author":"C Chatzakis","year":"2021","unstructured":"Chatzakis C, Cavoretto P, Sotiriadis A (2021) Gestational Diabetes Mellitus Pharmacological Prevention and Treatment. Curr Pharm Des 27:3833\u20133840. https:\/\/doi.org\/10.2174\/1381612827666210125155428","journal-title":"Curr Pharm Des"},{"key":"3380_CR11","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jogn.2021.10.007","volume":"51","author":"S Huang","year":"2022","unstructured":"Huang S, Magny-Normilus C, McMahon E et al (2022) Systematic Review of Lifestyle Interventions for Gestational Diabetes Mellitus in Pregnancy and the Postpartum Period. J Obstet Gynecol Neonatal Nurs 51:115\u2013125. https:\/\/doi.org\/10.1016\/j.jogn.2021.10.007","journal-title":"J Obstet Gynecol Neonatal Nurs"},{"key":"3380_CR12","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.cmet.2014.09.018","volume":"20","author":"M Foretz","year":"2014","unstructured":"Foretz M, Guigas B, Bertrand L et al (2014) Metformin: from mechanisms of action to therapies. Cell Metab 20:953\u2013966. https:\/\/doi.org\/10.1016\/j.cmet.2014.09.018","journal-title":"Cell Metab"},{"key":"3380_CR13","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ajog.2017.06.003","volume":"217","author":"R Romero","year":"2017","unstructured":"Romero R, Erez O, Huttemann M et al (2017) Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity. Am J Obstet Gynecol 217:282\u2013302. https:\/\/doi.org\/10.1016\/j.ajog.2017.06.003","journal-title":"Am J Obstet Gynecol"},{"key":"3380_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1210\/endrev\/bnaa023","volume":"42","author":"TE LaMoia","year":"2021","unstructured":"LaMoia TE, Shulman GI (2021) Cellular and Molecular Mechanisms of Metformin Action. Endocr Rev 42:77\u201396. https:\/\/doi.org\/10.1210\/endrev\/bnaa023","journal-title":"Endocr Rev"},{"key":"3380_CR15","first-page":"74","volume":"41","author":"T Mai","year":"2019","unstructured":"Mai T, Zhang Y, Wu M (2019) Effect of metformin on pregnancy rate and incidence of gestational diabetes mellitus in overweight\/obese patients with polycystic ovary syndrome. Journal of Inner Mongolia Medical University 41:74\u201377","journal-title":"Journal of Inner Mongolia Medical University"},{"key":"3380_CR16","doi-asserted-by":"publisher","unstructured":"Qu X, Chen Y, Li H et al (2016) The preventive effect of early metformin administration on gestational diabetes mellitus in obese patients with pregnancy and the effect on fetal weight. Progress in Modern Biomedicine 16:6894\u20136897. https:\/\/doi.org\/10.13241\/j.cnki.pmb.2016.35.025","DOI":"10.13241\/j.cnki.pmb.2016.35.025"},{"key":"3380_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S2213-8587(18)30310-3","volume":"7","author":"JM Dodd","year":"2019","unstructured":"Dodd JM, Louise J, Deussen AR et al (2019) Effect of metformin in addition to dietary and lifestyle advice for pregnant women who are overweight or obese: the GRoW randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol 7:15\u201324. https:\/\/doi.org\/10.1016\/S2213-8587(18)30310-3","journal-title":"Lancet Diabetes Endocrinol"},{"key":"3380_CR18","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1080\/00365510802254620","volume":"68","author":"KJ Fougner","year":"2008","unstructured":"Fougner KJ, Vanky E, Carlsen SM (2008) Metformin has no major effects on glucose homeostasis in pregnant women with PCOS: results of a randomized double-blind study. Scand J Clin Lab Invest 68:771\u2013776. https:\/\/doi.org\/10.1080\/00365510802254620","journal-title":"Scand J Clin Lab Invest"},{"key":"3380_CR19","doi-asserted-by":"publisher","unstructured":"Doi SAR, Furuya-Kanamori L, Toft E et al (2020) Metformin in pregnancy to avert gestational diabetes in women at high risk: Meta-analysis of randomized controlled trials. Obes Rev 21:e12964. https:\/\/doi.org\/10.1111\/obr.12964","DOI":"10.1111\/obr.12964"},{"key":"3380_CR20","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1111\/j.1447-0756.2008.00856.x","volume":"34","author":"FH Nawaz","year":"2008","unstructured":"Nawaz FH, Khalid R, Naru T et al (2008) Does continuous use of metformin throughout pregnancy improve pregnancy outcomes in women with polycystic ovarian syndrome? J Obstet Gynaecol Res 34:832\u2013837. https:\/\/doi.org\/10.1111\/j.1447-0756.2008.00856.x","journal-title":"J Obstet Gynaecol Res"},{"key":"3380_CR21","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1159\/000268051","volume":"69","author":"FH Nawaz","year":"2010","unstructured":"Nawaz FH, Rizvi J (2010) Continuation of metformin reduces early pregnancy loss in obese Pakistani women with polycystic ovarian syndrome. Gynecol Obstet Invest 69:184\u2013189. https:\/\/doi.org\/10.1159\/000268051","journal-title":"Gynecol Obstet Invest"},{"key":"3380_CR22","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.mefs.2011.04.002","volume":"16","author":"AAAE Hameed","year":"2011","unstructured":"Hameed AAAE, Shreif HE, Mowafy HE (2011) The role of continuing metformin therapy during pregnancy in the reduction of gestational diabetes and improving pregnancy outcomes in women with polycystic ovary syndrome. Middle East Fertility Society Journal 16:204\u2013208","journal-title":"Middle East Fertility Society Journal"},{"key":"3380_CR23","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3109\/09513590.2010.540600","volume":"27","author":"S Khattab","year":"2011","unstructured":"Khattab S, Mohsen IA, Aboul Foutouh I et al (2011) Can metformin reduce the incidence of gestational diabetes mellitus in pregnant women with polycystic ovary syndrome? Prospective cohort study. Gynecol Endocrinol 27:789\u2013793. https:\/\/doi.org\/10.3109\/09513590.2010.540600","journal-title":"Gynecol Endocrinol"},{"key":"3380_CR24","first-page":"237","volume":"25","author":"JA Ainuddin","year":"2015","unstructured":"Ainuddin JA, Kazi S, Aftab S et al (2015) Metformin for preventing gestational diabetes in women with polycystic ovarian syndrome. J Coll Physicians Surg Pak 25:237\u2013241","journal-title":"J Coll Physicians Surg Pak"},{"key":"3380_CR25","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/j.1447-0756.2008.00876.x","volume":"35","author":"MR Begum","year":"2009","unstructured":"Begum MR, Khanam NN, Quadir E et al (2009) Prevention of gestational diabetes mellitus by continuing metformin therapy throughout pregnancy in women with polycystic ovary syndrome. J Obstet Gynaecol Res 35:282\u2013286. https:\/\/doi.org\/10.1111\/j.1447-0756.2008.00876.x","journal-title":"J Obstet Gynaecol Res"},{"key":"3380_CR26","doi-asserted-by":"publisher","first-page":"E448","DOI":"10.1210\/jc.2010-0853","volume":"95","author":"E Vanky","year":"2010","unstructured":"Vanky E, Stridsklev S, Heimstad R et al (2010) Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study. J Clin Endocrinol Metab 95:E448-455. https:\/\/doi.org\/10.1210\/jc.2010-0853","journal-title":"J Clin Endocrinol Metab"},{"key":"3380_CR27","first-page":"265","volume":"10","author":"A Jamal","year":"2012","unstructured":"Jamal A, Milani F, Al-Yasin A (2012) Evaluation of the effect of metformin and aspirin on utero placental circulation of pregnant women with PCOS. Iran J Reprod Med 10:265\u2013270","journal-title":"Iran J Reprod Med"},{"key":"3380_CR28","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/S2213-8587(15)00219-3","volume":"3","author":"C Chiswick","year":"2015","unstructured":"Chiswick C, Reynolds RM, Denison F et al (2015) Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol 3:778\u2013786. https:\/\/doi.org\/10.1016\/S2213-8587(15)00219-3","journal-title":"Lancet Diabetes Endocrinol"},{"key":"3380_CR29","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1056\/NEJMoa1509819","volume":"374","author":"A Syngelaki","year":"2016","unstructured":"Syngelaki A, Nicolaides KH, Balani J et al (2016) Metformin versus Placebo in Obese Pregnant Women without Diabetes Mellitus. N Engl J Med 374:434\u2013443. https:\/\/doi.org\/10.1056\/NEJMoa1509819","journal-title":"N Engl J Med"},{"key":"3380_CR30","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/jog.13477","volume":"44","author":"E Valdes","year":"2018","unstructured":"Valdes E, Sepulveda-Martinez A, Candia P et al (2018) Metformin as a prophylactic treatment of gestational diabetes in pregnant patients with pregestational insulin resistance: A randomized study. J Obstet Gynaecol Res 44:81\u201386. https:\/\/doi.org\/10.1111\/jog.13477","journal-title":"J Obstet Gynaecol Res"},{"key":"3380_CR31","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1055\/s-0038-1642632","volume":"40","author":"WB Sales","year":"2018","unstructured":"Sales WB, Nascimento IBD, Dienstmann G et al (2018) Effectiveness of Metformin in the Prevention of Gestational Diabetes Mellitus in Obese Pregnant Women. Rev Bras Ginecol Obstet 40:180\u2013187. https:\/\/doi.org\/10.1055\/s-0038-1642632","journal-title":"Rev Bras Ginecol Obstet"},{"key":"3380_CR32","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.diabet.2018.01.008","volume":"44","author":"HS Brink","year":"2018","unstructured":"Brink HS, Alkemade M, van der Lely AJ et al (2018) Metformin in women at high risk of gestational diabetes mellitus. Diabetes Metab 44:300\u2013302. https:\/\/doi.org\/10.1016\/j.diabet.2018.01.008","journal-title":"Diabetes Metab"},{"key":"3380_CR33","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S2213-8587(19)30002-6","volume":"7","author":"TS Lovvik","year":"2019","unstructured":"Lovvik TS, Carlsen SM, Salvesen O et al (2019) Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol 7:256\u2013266. https:\/\/doi.org\/10.1016\/S2213-8587(19)30002-6","journal-title":"Lancet Diabetes Endocrinol"},{"key":"3380_CR34","first-page":"79","volume":"47","author":"J Xu","year":"2019","unstructured":"Xu J (2019) Study on the effect of metformin treatment on pregnancy rate and incidence of gestational diabetes in overweight\/obese patients with PCOS. Women\u2019s Health Research 47:79","journal-title":"Women's Health Research"},{"key":"3380_CR35","first-page":"122","volume":"17","author":"M Xie","year":"2021","unstructured":"Xie M, Gao M, Meng X (2021) Effect of metformin on pregnancy rate and incidence of gestational diabetes mellitus in patients with PCOS. Journal of Practical Diabetology 17:122\u2013123","journal-title":"Journal of Practical Diabetology"},{"key":"3380_CR36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1471-2288-8-22","volume":"8","author":"A Lundh","year":"2008","unstructured":"Lundh A, Gotzsche PC (2008) Recommendations by Cochrane Review Groups for assessment of the risk of bias in studies. BMC Med Res Methodol 8:22. https:\/\/doi.org\/10.1186\/1471-2288-8-22","journal-title":"BMC Med Res Methodol"},{"key":"3380_CR37","unstructured":"Wells GA, Shea BJ, O'Connell D et al (2000) The Newcastle\u2013Ottawa Scale (NOS) for Assessing the Quality of Non-Randomized Studies in Meta-Analysis"},{"key":"3380_CR38","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ et al (2003) Measuring inconsistency in meta-analyses. BMJ 327:557\u2013560. https:\/\/doi.org\/10.1136\/bmj.327.7414.557","journal-title":"BMJ"},{"key":"3380_CR39","doi-asserted-by":"publisher","first-page":"9804708","DOI":"10.1155\/2019\/9804708","volume":"2019","author":"L Guo","year":"2019","unstructured":"Guo L, Ma J, Tang J et al (2019) Comparative Efficacy and Safety of Metformin, Glyburide, and Insulin in Treating Gestational Diabetes Mellitus: A Meta-Analysis. J Diabetes Res 2019:9804708. https:\/\/doi.org\/10.1155\/2019\/9804708","journal-title":"J Diabetes Res"},{"key":"3380_CR40","doi-asserted-by":"publisher","unstructured":"Balsells M, Garcia-Patterson A, Sola I et al (2015) Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis. BMJ 350:h102. https:\/\/doi.org\/10.1136\/bmj.h102","DOI":"10.1136\/bmj.h102"},{"key":"3380_CR41","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1080\/14767058.2016.1228061","volume":"30","author":"Y Feng","year":"2017","unstructured":"Feng Y, Yang H (2017) Metformin - a potentially effective drug for gestational diabetes mellitus: a systematic review and meta-analysis. J Matern Fetal Neonatal Med 30:1874\u20131881. https:\/\/doi.org\/10.1080\/14767058.2016.1228061","journal-title":"J Matern Fetal Neonatal Med"},{"key":"3380_CR42","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","volume":"60","author":"G Rena","year":"2017","unstructured":"Rena G, Hardie DG, Pearson ER (2017) The mechanisms of action of metformin. Diabetologia 60:1577\u20131585. https:\/\/doi.org\/10.1007\/s00125-017-4342-z","journal-title":"Diabetologia"},{"key":"3380_CR43","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5603\/GP.a2020.0149","volume":"92","author":"M Skibinska","year":"2021","unstructured":"Skibinska M, Zurawska-Klis M, Krekora M et al (2021) Metformin administration during pregnancy - current insight. Ginekol Pol 92:46\u201350. https:\/\/doi.org\/10.5603\/GP.a2020.0149","journal-title":"Ginekol Pol"},{"key":"3380_CR44","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1016\/j.mayocp.2020.02.019","volume":"95","author":"AM Egan","year":"2020","unstructured":"Egan AM, Dow ML, Vella A (2020) A Review of the Pathophysiology and Management of Diabetes in Pregnancy. Mayo Clin Proc 95:2734\u20132746. https:\/\/doi.org\/10.1016\/j.mayocp.2020.02.019","journal-title":"Mayo Clin Proc"},{"key":"3380_CR45","doi-asserted-by":"publisher","unstructured":"Plows JF, Stanley JL, Baker PN et al (2018) The Pathophysiology of Gestational Diabetes Mellitus. Int J Mol Sci 19. https:\/\/doi.org\/10.3390\/ijms19113342","DOI":"10.3390\/ijms19113342"},{"key":"3380_CR46","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1055\/a-0603-3394","volume":"128","author":"J Zhao","year":"2020","unstructured":"Zhao J, Liu X, Zhang W (2020) The Effect of Metformin Therapy for Preventing Gestational Diabetes Mellitus in Women with Polycystic Ovary Syndrome: A Meta-Analysis. Exp Clin Endocrinol Diabetes 128:199\u2013205. https:\/\/doi.org\/10.1055\/a-0603-3394","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"3380_CR47","doi-asserted-by":"publisher","unstructured":"Sanchez-Garrido MA, Tena-Sempere M (2020) Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies. Mol Metab 35:100937. https:\/\/doi.org\/10.1016\/j.molmet.2020.01.001","DOI":"10.1016\/j.molmet.2020.01.001"},{"key":"3380_CR48","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.cca.2019.11.003","volume":"502","author":"X Zeng","year":"2020","unstructured":"Zeng X, Xie YJ, Liu YT et al (2020) Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity. Clin Chim Acta 502:214\u2013221. https:\/\/doi.org\/10.1016\/j.cca.2019.11.003","journal-title":"Clin Chim Acta"},{"key":"3380_CR49","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1093\/humrep\/deaa077","volume":"35","author":"J Jin","year":"2020","unstructured":"Jin J, Ma Y, Tong X et al (2020) Metformin inhibits testosterone-induced endoplasmic reticulum stress in ovarian granulosa cells via inactivation of p38 MAPK. Hum Reprod 35:1145\u20131158. https:\/\/doi.org\/10.1093\/humrep\/deaa077","journal-title":"Hum Reprod"},{"key":"3380_CR50","doi-asserted-by":"publisher","unstructured":"Shpakov AO (2021) Improvement Effect of Metformin on Female and Male Reproduction in Endocrine Pathologies and Its Mechanisms. Pharmaceuticals (Basel) 14. https:\/\/doi.org\/10.3390\/ph14010042","DOI":"10.3390\/ph14010042"},{"key":"3380_CR51","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1124\/dmd.119.088435","volume":"48","author":"MZ Liao","year":"2020","unstructured":"Liao MZ, Flood Nichols SK, Ahmed M et al (2020) Effects of Pregnancy on the Pharmacokinetics of Metformin. Drug Metab Dispos 48:264\u2013271. https:\/\/doi.org\/10.1124\/dmd.119.088435","journal-title":"Drug Metab Dispos"},{"key":"3380_CR52","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/joim.12903","volume":"286","author":"GP Arora","year":"2019","unstructured":"Arora GP, Akerlund M, Brons C et al (2019) Phenotypic and genotypic differences between Indian and Scandinavian women with gestational diabetes mellitus. J Intern Med 286:192\u2013206. https:\/\/doi.org\/10.1111\/joim.12903","journal-title":"J Intern Med"},{"key":"3380_CR53","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1530\/EJE-15-0060","volume":"172","author":"C Sommer","year":"2015","unstructured":"Sommer C, Jenum AK, Waage CW et al (2015) Ethnic differences in BMI, subcutaneous fat, and serum leptin levels during and after pregnancy and risk of gestational diabetes. Eur J Endocrinol 172:649\u2013656. https:\/\/doi.org\/10.1530\/EJE-15-0060","journal-title":"Eur J Endocrinol"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-023-03380-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-023-03380-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-023-03380-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T05:43:54Z","timestamp":1706075034000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-023-03380-z"}},"subtitle":["Metformin for gestational diabetes prevention"],"short-title":[],"issued":{"date-parts":[[2023,5,30]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["3380"],"URL":"https:\/\/doi.org\/10.1007\/s11845-023-03380-z","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,30]]},"assertion":[{"value":"13 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}